Establishment and characterization of five cell lines derived from human malignant gliomas. 1987

J T Rutka, and J R Giblin, and D Y Dougherty, and H C Liu, and J R McCulloch, and C W Bell, and R S Stern, and C B Wilson, and M L Rosenblum
Department of Neurological Surgery, School of Medicine, University of California, San Francisco 94143.

We established and characterized five cell lines derived from human malignant gliomas (four glioblastomas multiforme and one highly anaplastic astrocytoma). All cell lines exhibited tumor cell morphology and growth kinetics, and anchorage-independent growth in soft agar. Cytogenetic analysis revealed significant aneuploidy in all five cases as well as clonal chromosomal alterations unique to each cell line. No cell line was tumorigenic in athymic mice. Two of the cell lines were sensitive to carmustine (BCNU) in monolayer and soft-agar cultures. Electron microscopy showed marked variability between cell lines in the number and structure of intracytoplasmic organelles; SF-126 formed collagen fibers in vitro. Immunohistochemical analysis of the surgical specimens showed variable expression of glial fibrillary acidic protein (GFAP) in malignant astrocytes; positive immunostaining for glycoproteins of the extracellular matrix was found predominantly in perivascular regions. In early-passage cultures, only cell line SF-295 expressed GFAP; at establishment, none of the cell lines expressed GFAF or glutamine synthetase. Fibronectin and laminin were expressed by all cell lines in early-passage culture, but expression of these glycoproteins at establishment was variable. Only SF-126 was positively identified by immunostains for procollagen III; this was also the only cell line in which DEAE-cellulose chromatography and SDS-PAGE demonstrated interstitial collagen synthesis. These well-characterized glioma-derived cell lines may now serve as useful tools with which to study the cell biology of gliomas. The synthesis of interstitial collagen by a glioma-derived cell line may suggest a derivation from vascular mesenchymal elements, either reactive or transformed, in the original heterogeneous malignant glioma, rather than from a glial precursor cell.

UI MeSH Term Description Entries
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell

Related Publications

J T Rutka, and J R Giblin, and D Y Dougherty, and H C Liu, and J R McCulloch, and C W Bell, and R S Stern, and C B Wilson, and M L Rosenblum
January 1991, International journal of cancer,
J T Rutka, and J R Giblin, and D Y Dougherty, and H C Liu, and J R McCulloch, and C W Bell, and R S Stern, and C B Wilson, and M L Rosenblum
December 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
J T Rutka, and J R Giblin, and D Y Dougherty, and H C Liu, and J R McCulloch, and C W Bell, and R S Stern, and C B Wilson, and M L Rosenblum
June 2005, Neuropathology : official journal of the Japanese Society of Neuropathology,
J T Rutka, and J R Giblin, and D Y Dougherty, and H C Liu, and J R McCulloch, and C W Bell, and R S Stern, and C B Wilson, and M L Rosenblum
September 1989, Human cell,
J T Rutka, and J R Giblin, and D Y Dougherty, and H C Liu, and J R McCulloch, and C W Bell, and R S Stern, and C B Wilson, and M L Rosenblum
October 1985, Clinical orthopaedics and related research,
J T Rutka, and J R Giblin, and D Y Dougherty, and H C Liu, and J R McCulloch, and C W Bell, and R S Stern, and C B Wilson, and M L Rosenblum
September 1997, Gynecologic oncology,
J T Rutka, and J R Giblin, and D Y Dougherty, and H C Liu, and J R McCulloch, and C W Bell, and R S Stern, and C B Wilson, and M L Rosenblum
July 1995, Chinese medical journal,
J T Rutka, and J R Giblin, and D Y Dougherty, and H C Liu, and J R McCulloch, and C W Bell, and R S Stern, and C B Wilson, and M L Rosenblum
January 1992, Anticancer research,
J T Rutka, and J R Giblin, and D Y Dougherty, and H C Liu, and J R McCulloch, and C W Bell, and R S Stern, and C B Wilson, and M L Rosenblum
April 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace,
J T Rutka, and J R Giblin, and D Y Dougherty, and H C Liu, and J R McCulloch, and C W Bell, and R S Stern, and C B Wilson, and M L Rosenblum
January 1995, Oncology research,
Copied contents to your clipboard!